ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
SenesTech Inc

SenesTech Inc (SNES)

3.11
0.35
(12.68%)
Closed December 24 4:00PM
3.11
0.00
( 0.00% )
Pre Market: 6:06AM

Professional-Grade Tools, for Individual Investors.

SNES News

Official News Only

SNES Discussion

View Posts
einstock einstock 5 days ago
SNES SenesTech Summary
Second Mouse (Google Doc)
👍️0
TrendTrade2016 TrendTrade2016 1 week ago
SNES SECOND ROUND POP
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
SNES MONSTER
👍️ 1
JPetroInc JPetroInc 2 weeks ago
just WoW...!

1-Mil. float - just INSANE...!

"As we finish 2024, we have a number of initiatives set to be significant contributors to top line growth, including the recent approval to sell Evolve on third party e-commerce platforms; multiple large international orders set to ship before the end of the year; adoption by key brick-and-mortar retailers; potential deployment in New York City and other key municipalities; and broader adoption of our new Evolve Rat and Mouse solutions through existing channels."

"As the only manufacturer of products registered or designated by the U.S. EPA for the restriction of rodent reproduction, we have a tremendous opportunity ahead of us to 'Change the Game' of how the rodent control industry addresses rodent infestations. With Evolve, and its improved form factor, economical price point, proven efficacy, and lengthy shelf life, we have addressed all the key product attribute requirements communicated to us by the industry. We look forward to continued rapid adoption of our innovative solutions." Fruendt concluded.

nice revenues, nice Big Box expansiuon of product, nice revenues incoming, proprietray products expanding across all borders - nice...

EOM
👍️ 1
TrendTrade2016 TrendTrade2016 2 weeks ago
SNES ROCK STAR OF THE DAY
👍️0
gfp927z gfp927z 3 months ago
SenesTech - >>> New York City Council passes bill to use birth control on rats


WPIX New York

by Matthew Euzarraga

September 26, 2024


https://www.yahoo.com/news/york-city-council-passes-bill-221403507.html


NEW YORK (PIX11) — The New York City Council voted Thursday to use birth control on rats.

According to the bill, a local rat contraceptive pilot program will begin in a small section of the city 180 days after the bill is passed.

“For no less than 12 months immediately after the deployment of the rat contraceptive, the department shall perform monthly inspections of each pilot program area and each pilot program comparison area,” read the newly passed bill. “During such monthly inspections of the pilot program areas, the department shall track the amount of rat contraceptive in each rat contraceptive dispenser.”

The pilot program is inspired by New York City’s beloved Flaco the owl, who died earlier this year with rat poison in his system.

New York City Council member Shaun Abreu, the bill’s sponsor, said he has worked with ContraPest, a type of birth control, to find a less harmful way to reduce the New York City rat population. Abreu also noted that other steps, such as having New Yorkers put trash in containers, will make the contraceptive more effective.

ContraPest has been utilized by the city in the past, but it was not practical, according to a veterinarian with over 12 years of experience who spoke to PIX11 News.

👍️0
dennisv dennisv 12 months ago
To have dry powder in this company!
👍️0
dennisv dennisv 12 months ago
Waiting For Happy Hour!
👍️0
dennisv dennisv 12 months ago
This could explode and running like a white horse!
👍️0
BurgerKing82 BurgerKing82 12 months ago
It would be nice to get more buying volume.....the news was probably expected.....Still,Green on a red day is welcomed
👍️0
Anite Anite 12 months ago
https://finance.yahoo.com/news/senestech-signs-expanded-distribution-agreement-140000018.html

SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces the expansion ...
👍️0
Anite Anite 12 months ago
earnings per share estimates for shares of SenesTech in a research report issued on Thursday, December 28th. HC Wainwright analyst A. Dayal now forecasts that the company will post earnings of ($30.28) per share for the year, up from their prior estimate of ($45.74). HC Wainwright has a “Buy” rating and a $3.50 price target on the stock. The consensus estimate for SenesTech’s current full-year earnings is ($30.28) per share
👍️0
BurgerKing82 BurgerKing82 12 months ago
Definitely seems like it could be.... wouldn't expect much for Tues/Wed.... hopefully it stabilizes and works it's way to the 1.40s.....Gotta think,with some good news....It could run...
👍️ 1
al dean al dean 12 months ago
I think it is runner as well as the orders make this more desirable. They have a good product that is raising interest. I'm thinking MMs lowered this Friday to have shares to sell next Tuesday. 3 day weekends are rare, so big group of buyers on Tuesday ? That's my take on it .
👍️ 1
BurgerKing82 BurgerKing82 12 months ago
Well...I guess there it is a 1 day.......yikes...if it could just go back to the 1.40s LOL
👍️0
BurgerKing82 BurgerKing82 12 months ago
Hate to say it....But it seems like a lot of shares have traded to get a %116 rise...Idk
👍️0
subslover subslover 12 months ago
It's got a tiny float so it could go sky-high. Very erratic trading
👍️0
BurgerKing82 BurgerKing82 12 months ago
Got in way late at 1.48....probably regret it lol
👍️0
subslover subslover 12 months ago
Excellent call brother. :)
👍️0
IVANj IVANj 12 months ago
Winner winner$$$
👍️0
sleepthief sleepthief 12 months ago
I don’t think it matters right now. This is a runner. Expecting 2+ today IMO
👍️0
subslover subslover 12 months ago
Figure this out = The number of shares of common stock outstanding as of November 8, 2023: 3,631,060
👍️0
sleepthief sleepthief 12 months ago
China
👍️0
subslover subslover 12 months ago
Whats the good word?
👍️0
IVANj IVANj 1 year ago
Easy $
👍️0
Monksdream Monksdream 1 year ago
SNES new 52 week low
👍️0
willlbone willlbone 1 year ago
Dilution approved.
👍️0
willlbone willlbone 1 year ago
R/S approved.
👍️0
Awl416 Awl416 1 year ago
Hard not to laugh at that AH
👍️0
subslover subslover 1 year ago
SenesTech Launches EVOLVE Soft Bait Fertility Solution in California-based Ace Hardware Franchise Locations
PHOENIX, Nov. 27, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced the launch of Evolve™ Soft Bait ("Evolve") at Ace Hardware franchise locations in California. Evolve is the first and only soft bait product featuring breakthrough, next generation technology that targets rodent populations by using nonlethal methods to restrict fertility. The franchise has also recently began selling SenesTech's expanded line of fertility control products, including the Isolate™ and Elevate™ bait systems for ContraPest®. This marks the first time a traditional retail store has offered SenesTech's rodent fertility control solutions.


"California-based Scarborough Ace Hardware, as well as Scarborough Home and Garden, are the first retail outlets to commit to SenesTech's line. They will also be among the first in the U.S. to receive shipments of Evolve based on their recent preorder," commented Joel Fruendt, SenesTech's President and Chief Executive Officer. "We expect the penetration of retail and big box to rapidly accelerate, especially with the launch of Evolve and its retail friendly soft bait profile and packaging."

Evolve addresses the fundamental issue of rodent overpopulation by focusing on the rapid reproduction of rats. Evolve controls the population by reducing or eliminating the fertility of rats, rather than trying to keep up with the growing numbers of an infestation with poisons alone. The active ingredient in Evolve effectively reduces fertility in rodents in numerous independent studies. Evolve is highly palatable to rats, easy to deploy, offers diverse placement in many different environments and is priced competitively to rodenticide alternatives.

"Evolve was developed to offer customers a soft bait product that has similar efficacy to ContraPest, but in a format that is easier to deploy, and is ideally suited for use by do it yourself consumers. We are pleased to be partnering with the team at Scarborough Ace Hardware to provide their customers with an innovative solution to address their rodent issues," Fruendt expanded.

Crystal Maro from Scarborough Ace Hardware commented, "We put the ContraPest product line on the shelves recently and are already re-ordering due to high sales levels. The product is definitely starting to pick up, and with the Evolve soft bait now available, we expect interest and sales to accelerate. This area was overrun with rats after the CZU fire. Traps and poison can only get you so far, and both can cause harm to local wildlife and pets. People are very excited that there is an alternative."
👍️0
Invest-in-America Invest-in-America 1 year ago
SNES: And right now, a new Post-Mkt. HIGH!!
👍️0
Monksdream Monksdream 1 year ago
SNES new 52 week low
👍️0
Invest-in-America Invest-in-America 1 year ago
SNES: Some suckers-bait routines in the Pre-M here, but their PRODUCT has INSANE potential!!! (Good-bye 'Mouse Traps', inter alia???? What their stuff does to RODENTS, I wish it could do to REPUBLICANS as well!!)
👍️0
subslover subslover 1 year ago
SenesTech Announces Third Quarter 2023 Financial Results
Revenue Growth Up 44%; Net Loss Improved by Almost $700,000

Company to Begin Shipments of Evolve Soft Bait Next Week

Expected to Be a Key Driver of Revenue Growth

PHOENIX, Nov. 9, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced financial results for the third quarter of 2023.


"We accelerated our growth trajectory during the third quarter with strong 44% year-over-year growth in revenues driven by the initiatives we have undertaken to drive sales, improve our product quality, and expand our product options," commented Joel Fruendt, SenesTech's President and Chief Executive Officer. "We expect this growth to further accelerate as we launch our Evolve Soft Bait, the first and only soft bait developed to control pest populations using a breakthrough technology that targets the rat population where it starts, by restricting fertility through nonlethal methods. We have received pre-orders and expect to start shipping product next week."

Sales growth during the third quarter was led by increases in nearly every key market segment, including agribusiness, zoos and sanctuaries, and commercial. The Company also continued to experience sequential revenue growth and an improvement of its return on marketing investment within its e-commerce platform following the successful reconfiguration of those operations earlier this year. Overall, the various initiatives led to an improvement of nearly $700,000 in its net loss and Adjusted EBITDA loss compared to the year-ago period.

Fruendt continued, "We have made several operational improvements to drive revenue growth more efficiently, with an objective of reaching profitability in the near future."

The launch of the Evolve Soft Bait is expected to be a significant step in expanding SenesTech's reach within key market verticals, including 'big box' retailers, key e-commerce channels, and pest management professionals. Evolve is highly palatable to rats, easy to deploy, and offers diverse placement in many different and complex environments, including municipalities, parks, recreation facilities, sports venues, food processing facilities, correctional facilities, subways, medical facilities, agribusiness, zoos, and residential locations. Importantly, Evolve is priced competitively to currently available rodenticide alternatives.

"Our initial focus will be on the commercial market and key industry distributors. In addition, we have established our vendor account with Amazon and are pursuing the process of selling through their portal, as well as other e-commerce providers. Finally, we are initiating discussions with key big box retailers to offer Evolve on their shelves," added Fruendt.

The introduction of Evolve continues SenesTech's recent string of innovative product offerings designed to provide customers with the effectiveness of fertility control in the format that fits their needs. In July 2023, the Isolate Bait System was launched as a more efficient and easier-to-use liquid bait system, which integrates both the tank and tray as a single unit. In October, Isolate represented over a third of all unit sales. Last year, the Company introduced Elevate, an easily deployed system for mounting in the rafters of barns, granaries, attics, lofts, and storage and manufacturing facilities. Year-to-date, nearly 5,500 Elevate systems have been deployed in various agricultural settings.

"Product innovation is key to our future success. Building upon the recent introductions of the Isolate and Elevate bait systems for ContraPest, Evolve was developed to offer customers a soft bait product that has similar efficacy to ContraPest, but in a format that is easier to deploy and in a format they can use daily in their integrated pest management programs," Fruendt continued. "A key differentiating feature for Evolve is the opportunity to distribute through key big box retailers and e-commerce providers. We are in active negotiations, with a goal to develop partnerships that will dramatically increase the adoption of the Evolve solution and to set SenesTech up for tremendous success in the future."

Q3 2023 Highlights

Revenue during Q3 2023 was $360,000 compared to $250,000 in Q3 2022, an increase of 44%.
Gross profit during Q3 2023 was $176,000, for a gross profit margin of 49%, compared to $122,000, or a gross profit margin of 49%, in Q3 2022.
Net loss during Q3 2023 was $1.9 million, compared with a net loss of $2.6 million for Q3 2022.
Adjusted EBITDA loss, which is a non-GAAP measure of operating performance, for Q3 2023 was $1.7 million compared to $2.4 million in Q3 2022.
Cash at the end of September 2023 was $2.1 million.
Use of Non-GAAP Measure

Adjusted EBITDA is a non-GAAP measure. However, this measure is not intended to substitute for those financial measures reported in accordance with GAAP. Adjusted EBITDA has been included because management believes that, when considered together with the GAAP figures, it provides meaningful information related to our operating performance and liquidity and can enhance an overall understanding of financial results and trends. Adjusted EBITDA may be calculated by us differently than other companies that disclose measures with the same or similar term. See our attached financials for a reconciliation of this non-GAAP measure to the nearest GAAP measure.

Conference Call Details

Date and Time: Thursday, November 9, 2023, at 5:00 pm ET

Call-in Information: Interested parties can access the conference call by dialing (844) 308-3351 or (412) 317-5407.

Live Webcast Information: Interested parties can access the conference call via a live Internet webcast, which is available in the Investor Relations section of the Company's website at http://senestech.investorroom.com/ or https://app.webinar.net/J3D79bAZjVx.

Replay: A teleconference replay of the call will be available for seven days at (877) 344-7529 or (412) 317-0088, replay access code 6400460. A webcast replay will be available in the Investor Relations section of the Company's website at http://senestech.investorroom.com for 90 days or https://app.webinar.net/J3D79bAZjVx.

About SenesTech

We are committed to improving the health of the world by humanely managing animal pest populations through fertility control. We are experts in fertility control to manage animal pest populations. We invented ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, and Evolve, an EPA-designated minimum risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. We strive for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable.

For more information visit https://senestech.com/ and https://contrapeststore.com.

Safe Harbor Statement

This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, our expectation that the Evolve Soft Bait solution will be a key driver to revenue growth; our expectation that our growth will further accelerate into the future as we launch our Evolve Soft Bait solution; our expectation that we will start shipping Evolve Soft Bait product next week; our objective to drive the business towards profitability; our expectation that the launch of the Evolve Soft Bait solution will be a significant step in expanding our reach within key market verticals, including 'big box' retailers, key e-commerce channels, and leading industry pest management professionals; our belief that product innovation is key to our future success; and our goal to develop partnerships that will dramatically increase the adoption of the Evolve solution and set us up for tremendous success in the future. Forward-looking statements may describe future expectations, plans, results, or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations; our ability to maintain compliance with Nasdaq's continued listing requirements; and regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.
👍️0
Monksdream Monksdream 1 year ago
SNES new 52 week low
👍️0
Monksdream Monksdream 1 year ago
SNES new 52 week low

👍️0
Monksdream Monksdream 1 year ago
SNES new 52 week low
👍️0
Monksdream Monksdream 1 year ago
SNES new 52 week low
👍️0
subslover subslover 2 years ago
PHOENIX, May 8, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced the deployment of ContraPest® into one of the largest agricultural grain export companies in the world.


"20% of the world's stored food supply is lost to rats' consumption and contamination, with estimates over 30% when specifically referring to grain storage and transport. It is a particularly difficult pest control challenge, as there is a constant influx of new rats when grain is loaded or delivered, and the potential use of lethal tools is limited. This is one of the pest control challenges that led the Company to develop ContraPest," said Joel Fruendt, SenesTech's President and CEO.

Mr. Fruendt continued, "With this customer and this initial deployment, our experts worked with the pest management professionals to develop and deploy ContraPest as an addition to the existing integrated pest management (IPM) program. If this follows the success we have seen in other customer segments, this initial deployment represents a significant account growth potential."

"This may also be a useful entry point for ex-U.S. markets," concluded Mr. Fruendt. "We hope to have further news about this in the near future."

About SenesTech
We are the experts in rat fertility control. Our passion is to create a healthy environment by better controlling rat pest populations. We keep an inescapable truth in mind. Two rats and their descendants can be responsible for the birth of up to 15,000 pups after a year. We invented ContraPest, the only U.S. EPA registered contraceptive for male and female rats. ContraPest fits seamlessly into all integrated pest management programs, greatly improving the overall goal of effective rat management. We strive for clean cities, efficient businesses, and happy households – with a product that was designed to be effective and sustainable without killing rats. At SenesTech, we are committed to improving the health of the world by humanely managing animal populations through fertility control.

For more information visit https://senestech.com/ and https://contrapeststore.com.
👍️0
Roadtojourney Roadtojourney 2 years ago
How is this even trading?? There mcap is not even 2 mil??imo
👍️0
PennyPusher786 PennyPusher786 2 years ago
I knew these shit bags were gong to drop an offering... if you can't Make money, claim bankruptcy and sell your asses off, move to OTC where you can afford to stay... screwing shareholders with your failed business model. Don't deserve a single penny of investment
👍️0
stock1ace1 stock1ace1 2 years ago
Ill buy some here premarket 610k o/s whats float any idea?
👍️0
eur06 eur06 2 years ago
Good luck dino!!
👍️0
PennyPusher786 PennyPusher786 2 years ago
LOL fu*ck nasdaq... I'm gong to stick to the OTC lol this was expected.
👍️0
PennyPusher786 PennyPusher786 2 years ago
Reminding me of TBLT right now
👍️0
PennyPusher786 PennyPusher786 2 years ago
That s1A sounds shady
👍️0
PennyPusher786 PennyPusher786 2 years ago
This is a sh!t hold... i bet they drop an offering tomorrow... I'm thinking fuc*k this ticker let them short it to death
👍️0
PennyPusher786 PennyPusher786 2 years ago
Agreed, it is possible, just reflecting on recent RS tickers, they stagnated or dumped in following days... the good ones were running all summer and by Fall, stagnation and dumping and i don't see this as a company which can support SP growth moving forward... All companies are tanking due to QE, they are going back to their true values... who knows if this hits $10-$15, I'm out in Pre Market or early AM
👍️0
dinogreeves dinogreeves 2 years ago
I am sitting on 40,000 shares right now. After reverse split will have 2000 shares. I say we move up another 100-150% after the reverse split and call it for the day.
👍️0
PennyPusher786 PennyPusher786 2 years ago
I still think, IF there is any buying interest in this one, we may see a run above .40 by close oulr AH. depends how many want in if any.... not much interest on Twitter, IHuB or Stockwits....

MOON tried to pump it on Twitter, but lack of interest... All that recession and high interest talk i guess lol...
👍️0

Your Recent History

Delayed Upgrade Clock